We are honored to share that Windshire's president, James Blackwell, PhD, MBA/MS will join Amnon…
Process Development Improvements Post-Pandemic
Dr. Blackwell, Founder and Principal Consultant at The Windshire Group, comments on learnings for process development as a result of meeting pandemic challenges. There are considerations for routine development for conventional therapeutics and for future pandemic responses.
BioPharm International:
https://lnkd.in/ec2gjFA
Pharmaceutical Technology:
https://lnkd.in/ePtb4VC
Process Development Forum (joint project with Cytiva):
https://lnkd.in/eAt9ZCv